An open label randomized controlled trial of tacrolimus versus cyclosporine treatment for severe ulcerative colitis

An open label randomized controlled trial of tacrolimus versus cyclosporine treatment for severe ulcerative colitis - Tacrolimus versus cyclosporine treatment for severe UC

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010776

Enrollment

Registered

2013-06-01

Start date

2013-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

tacrolimus (Prograf) cyclosporine (Sandimmune)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Severe ulcerative colitis

Exclusion criteria

Exclusion criteria: Patients who had treated with tacrolimus or cyclosporine

Design outcomes

Primary

Measure	Time frame
Clinical response rates at 2 weeks of treatment	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026